Discovery of R-142086 as a factor Xa (FXa) inhibitor: syntheses and structure-activity relationships of cinnamyl derivatives.
Chem Pharm Bull (Tokyo)
; 57(1): 22-33, 2009 Jan.
Article
en En
| MEDLINE
| ID: mdl-19122312
ABSTRACT
To develop a novel and effective anticoagulant with potent and selective factor Xa (FXa) inhibitory activity, a new series of cinnamyl derivatives with enhanced lipophilicity and prodrug forms were synthesized and their biological activities were evaluated. As a result, we found that cinnamyl derivative (N-[4-[1-(acetimidoyl)piperidin-4-yloxy]-3-carbamoylphenyl]-N-[(Z)-3-(3-amidinophenyl)-2-fluoro-2-propenyl]sulfamoyl)acetic acid dihydrochloride (26d, R-142086) with a fluorine atom on the double bond exhibited potent anticoagulant activity and no mutagenic potential. Moreover, orally administered R-142086 exhibited potent anti-FXa activity and anticoagulant activity in dogs.
Buscar en Google
Colección:
01-internacional
Banco de datos:
MEDLINE
Asunto principal:
Sulfonamidas
/
Antitrombina III
/
Cinamatos
/
Inhibidores del Factor Xa
/
Amidinas
/
Anticoagulantes
Límite:
Animals
/
Humans
/
Male
Idioma:
En
Revista:
Chem Pharm Bull (Tokyo)
Año:
2009
Tipo del documento:
Article
País de afiliación:
Japón